Posted inGenetics
Insilico, SK Launch Up-to-$2.5B Neuroimmune AI Drug Collaboration
Alex Zhavoronkov, PhD, CEO of Insilico Medicine, inside the company’s robotics lab in Suzhou, China.[Insilico Medicine] Insilico Medicine will partner…
Posted inGenetics
Backed by $165M, Bionyra Pharma Launches to Advance Inflammatory Disease Biologics
Inflammatory bowel disease (illustration). [Christoph Burgstedt/Science Photo Library/Getty Images] Though he is trained as a gastroenterologist and scientist, Frédéric Marrache,…
Posted inGenetics
Genome Editing at the Turning Point—Bringing CRISPR to Clinical Reality
Laura Sepp-Lorenzino, PhD Former CSOIntellia Therapeutics Panelist Laura Sepp-Lorenzino, PhD Laura Sepp-Lorenzino, PhD, is scientific advisor and former chief scientific…
Posted inGenetics
Intravesical CAR T-Cell Therapy Reduces Bladder Cancer Growth in Preclinical Model
Source: wildpixel/Getty Images Researchers at Weill Cornell Medicine and Roswell Park Comprehensive Cancer Center have genetically engineered CAR T cells…
Posted inGenetics
Nipah and Hendra Viruses: Antibody Cocktail Provides Complete Protection in Hamster Model
Nipah virus [RUSLANAS BARANAUSKAS / Science Photo Library / Getty Images] Nipah virus—and the closely related Hendra virus—are zoonotic pathogens…
Posted inGenetics
Circio’s circVec and Tcelltech’s nanoSMAR Technologies Combined to Generate Nextgen In vivo CAR-T and TCR-T Cells
T cells targeting cancer cells. [Luis M Molina/Getty Images] Norway-based Circio and Tcelltech, based in Germany, will collaborate using the…
Posted inGenetics
AI Framework Surfaces New CAR T Target with Multi‑Cancer Potential
Credit: NEMES LASZLO/SCIENCE PHOTO LIBRARY/ Getty Images A new study in Cell describes an AI‑enabled strategy that could accelerate the…
Posted inGenetics
Antibiotics Trigger Protein Sharing Among Bacteria, Aiding Persister Cells
New research headed by scientists at Baylor College of Medicine suggests that when bacteria are under antibiotic attack, it is…
Posted inGenetics
Merck KGaA to Acquire Bio-Techne for $11.3B, Expanding Life Science Tools Presence
A Merck KGaA, Darmstadt, Germany, researcher at work. Merck KGaA has agreed to acquire Bio-Techne for approximately $11.3 billion, in…
Posted inGenetics
BIO 2026: FDA Leadership Confront Workforce Losses, China Competition in Drug Development
Panelists during the FDA town hall at BIO 2026. (L to R) Lowell Zeta, JD, acting chief of staff at…